Abrin Pharma Private Limited
About Abrin Pharma Private Limited
Data last updated:
Abrin Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 19 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC328801. Its GSTIN is 10AAQCA4622H1ZZ (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilesh Kumar and Kumari Priyanka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 163 – 164 1st Floor Pocket – 6 Sector – 25 Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.54 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹94,440 (net margin 1.9%) and EBITDA of ₹99,325 (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 15% over five years.
Company details
Contact details
Abrin Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address163 – 164 1st Floor Pocket – 6 Sector – 25 Rohini, New Delhi, Delhi, India – 110085
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Abrin Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Abrin Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Abrin Pharma Private Limited, buy the company report.
Financials of Abrin Pharma Private Limited
FY 2025 filings availableAbrin Pharma Private Limited reported revenue of ₹48.54 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 25% growth in the latest year. EBITDA rose 438% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹99,325 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹94,440 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abrin Pharma Private Limited, buy the company report.
Board of directors of Abrin Pharma Private Limited
Abrin Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Kumar | Director | 19 Jan 2018 | 8 Years 9 Months | Current |
| Kumari Priyanka | Director | 19 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Abrin Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Barhuparkaimur Agriculture Producer Company Limited | ₹48.61 Lakh (FY 2025) | 1.0% | Kaimur, Bihar, India | |||
| BPG Star Exports Private Limited | ₹48.6 Lakh (FY 2025) | -15.0% | Nashik, Maharashtra, India | |||
| Amar Metachem Private Limited | ₹48.57 Lakh (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| H C Trading Private Limited | ₹48.54 Lakh (FY 2024) | 26.0% | Kolkata, West Bengal, India | |||
| Avani Natural Produce Private Limited | ₹48.54 Lakh (FY 2025) | -7.0% | Pune, Maharashtra, India | |||
| Abrin Pharma Private Limitedthis company | ₹48.54 Lakh (FY 2025) | ₹94,440 | 1.9% | 25.0% | New Delhi, Delhi, India | |
| Bioliz Pharmaceuticals Private Limited | ₹48.5 Lakh (FY 2025) | 19.0% | Mumbai, Maharashtra, India | |||
| Lifra Pipe Private Limited | ₹48.5 Lakh (FY 2025) | 467.0% | Bangalore, Karnataka, India | |||
| Maxilla Healthcare Private Limited | ₹48.48 Lakh (FY 2025) | 10443.0% | New Delhi, Delhi, India | |||
| Engenius Machineries and Services Private Limited | ₹48.45 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Saniplex Trading Private Limited | ₹48.37 Lakh (FY 2025) | -57.0% | Delhi, India |
To see the full peer comparison of Abrin Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Abrin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abrin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Abrin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAQCA4622H1ZZ | Bihar | Active | 12 Apr 2018 |
To see the full GST registrations and return filing status of Abrin Pharma Private Limited, buy the company report.
Recent activity
Abrin Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Anamika Sagar ceased to be Additional Director on 07 Dec 2021.
Frequently asked questions
Abrin Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 19 January 2018 (8+ years old) and is registered under CIN U74999DL2018PTC328801.
Abrin Pharma has 2 current directors:
- Nilesh Kumar - Director
- Kumari Priyanka - Director
The latest financial statements of Abrin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Abrin Pharma is 10AAQCA4622H1ZZ, registered in Bihar.
The CIN (Corporate Identification Number) of Abrin Pharma is U74999DL2018PTC328801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abrin Pharma was incorporated on 19 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Abrin Pharma by revenue are Barhuparkaimur Agriculture Producer Company Limited, BPG Star Exports Private Limited, Amar Metachem Private Limited, H C Trading Private Limited, Avani Natural Produce Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Anamika Sagar ceased to be Additional Director on 07 Dec 2021. Sadhana Sinha ceased to be Director on 30 Dec 2019. Sonam ceased to be Director on 07 Mar 2018. Abrin Pharma has 5 board changes on record in total.
The registered office of Abrin Pharma is at 163 – 164 1st Floor Pocket – 6 Sector – 25 Rohini, New Delhi, Delhi, India – 110085.
Abrin Pharma operates in the business services industry, in the other services segment.
Abrin Pharma can be reached at its registered office: 163 – 164 1st Floor Pocket – 6 Sector – 25 Rohini, New Delhi, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
